Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer.

doi:10.1245/s10434-010-0994-3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer.

Annals of surgical oncology - 1 Jun 2010

Bao Bo-Ying, Lin Victor C, Huang Shu-Hung, Pao Jiunn-Bey, Chang Ta-Yuan, Lu Te-Ling, Lan Yu-Hsuan, Chen Lu-Min, Ting Wen-Chien, Yang Wen-Hui, Hsieh Chi-Jeng, Huang Shu-Pin

Abstract excerpt

BACKGROUND: Bone metastases are the most critical complication of prostate cancer (PCa), resulting in severe morbidity and mortality. Tumor necrosis factor receptor superfamily member 11b (TNFRSF11B) is a critical regulator between PCa cells and the bone environment. Recently, TNFRSF11B rs1050534...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Osteoprotegerin

Share to Predictive Value of Tests

Share to Preoperative Care

Share to Proportional Hazards Models

Share to Prostatectomy

Share to Prostatic Neoplasms

Source

Open in PubMed

Identifiers

PMID: 20204532
DOI: 10.1245/s10434-010-0994-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20204532-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of tumor necrosis factor receptor superfamily member 11b polymorphism in prostate cancer.PMID 20204532Read ↗

Clinical significance of runt-related transcription factor 1 polymorphism in prostate cancer.Semantic proximity Read ↗

Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.Semantic proximity Read ↗

An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients.Semantic proximity Read ↗

Polymorphisms in tumor necrosis factor-A gene and prostate cancer risk in North Indian cohort.Semantic proximity Read ↗

Missense and Intronic Variants in HNF1A Affect Prostate Cancer Aggressiveness in Patients with Biochemical Recurrence.Semantic proximity Read ↗

The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.Semantic proximity Read ↗

Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.Semantic proximity Read ↗

Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients.Semantic proximity Read ↗

Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy.Semantic proximity Read ↗

Genetic variants of ADAM9 as potential predictors for biochemical recurrence in prostate cancer patients after receiving a radical prostatectomy.Semantic proximity Read ↗

Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.Semantic proximity Read ↗

SRD5A polymorphisms and biochemical failure after radical prostatectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.